- Home
- GSAT vs ALVO Comparison
GSAT vs ALVO Comparison
Compare GSAT & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSAT
- ALVO
- Stock Information
- Founded
- GSAT 2003
- ALVO 2013
- Country
- GSAT United States
- ALVO Luxembourg
- Employees
- GSAT N/A
- ALVO N/A
- Industry
- GSAT Telecommunications Equipment
- ALVO Biotechnology: Pharmaceutical Preparations
- Sector
- GSAT Consumer Discretionary
- ALVO Health Care
- Exchange
- GSAT Nasdaq
- ALVO Nasdaq
- Market Cap
- GSAT 3.0B
- ALVO 2.5B
- IPO Year
- GSAT 2006
- ALVO N/A
- Fundamental
- Price
- GSAT $18.46
- ALVO $11.44
- Analyst Decision
- GSAT Strong Buy
- ALVO Buy
- Analyst Count
- GSAT 3
- ALVO 1
- Target Price
- GSAT $43.33
- ALVO $18.00
- AVG Volume (30 Days)
- GSAT 645.0K
- ALVO 291.4K
- Earning Date
- GSAT 05-08-2025
- ALVO 05-07-2025
- Dividend Yield
- GSAT N/A
- ALVO N/A
- EPS Growth
- GSAT N/A
- ALVO N/A
- EPS
- GSAT N/A
- ALVO 0.34
- Revenue
- GSAT $253,901,000.00
- ALVO $587,890,000.00
- Revenue This Year
- GSAT $7.69
- ALVO $22.17
- Revenue Next Year
- GSAT $21.67
- ALVO $58.38
- P/E Ratio
- GSAT N/A
- ALVO $33.75
- Revenue Growth
- GSAT 14.55
- ALVO 413.92
- 52 Week Low
- GSAT $15.00
- ALVO $7.35
- 52 Week High
- GSAT $41.10
- ALVO $14.65
- Technical
- Relative Strength Index (RSI)
- GSAT 44.45
- ALVO 68.73
- Support Level
- GSAT $18.00
- ALVO $9.60
- Resistance Level
- GSAT $19.33
- ALVO $11.57
- Average True Range (ATR)
- GSAT 0.73
- ALVO 0.48
- MACD
- GSAT 0.04
- ALVO 0.17
- Stochastic Oscillator
- GSAT 39.11
- ALVO 85.98
About GSAT Globalstar Inc.
Globalstar Inc is a telecommunications company that derives revenue from the provision of mobile satellite services. Mobile satellite services are typically used by customers where existing terrestrial wireline and wireless communications networks are impaired or do not exist. The company provides communications services such as two-way voice and data transmission. In addition, one-way data transmission is also offered. Both services are offered using mobile or fixed devices. The company is an owner of satellite assets. The company generates the vast majority of its revenue within the United States.
About ALVO Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.